title: Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
authors.affiliation: HIV Community Program, Christiana Care Health Services, P.O. Box 1668, Wilmington, DE 19899-1668, USA. cjames@christianacare.org
authors.forename: Christopher W
authors.initials: CW
authors.lastname: James
authors.forename: Kelly C
authors.initials: KC
authors.lastname: McNelis
authors.forename: Susan
authors.initials: S
authors.lastname: Szabo
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000900:Anti-Bacterial Agents; D053626:Atovaquone; D002985:Clinical Protocols; D003622:Dapsone / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006739:Hospital Administration; D006801:Humans; D009285:Naphthoquinones / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D019233:Retreatment; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D009285:Naphthoquinones; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003622:Dapsone; D053626:Atovaquone